WHO ICTRP trial
A clinical study assessing how Sarcoboost improves physical strength, mobility…
CTRI/2025/12/098758 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/12/098758 |
|---|---|
| Public title | A clinical study assessing how Sarcoboost improves physical strength, mobility, and quality of life in people with Sarcopenia and Type 2 Diabetes Mellitus. |
| Scientific title | A Randomized, Controlled Study to Evaluate the Effect of Sarcoboost Supplementation on Physical Performance, Strength and Quality of Life in Patients with Sarcopenia and Type 2 Diabetes Mellitus (T2DM). - NIL |
| Primary sponsor | Meghmani Lifesciences Limited, |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | PMS |
| Phase | Post Marketing Surveillance |
| Countries | India |
| Conditions | Health Condition 1: M628- Other specified disorders of muscle Health Condition 2: E119- Type 2 diabetes mellitus without complications |
| Interventions | Intervention1: 5g Sarcoboost (3g CaHMB + 300mg Magnesium + 600 IU Vitamin D) + Resistance Training + Balanced Diet: Administered once daily for twelve weeks, with the option to extend usage for an additional 3 months if continuing in the… |
| Registration date | Oct 12, 2025 |
| Target size | 500 |
| Secondary IDs | CT-25-005 Version 1.0 dated 06 Aug 25 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: